Hemophilia gene therapy represents a groundbreaking advancement in the treatment of hemophilia B, a genetic disorder that impairs the body’s ability to produce the necessary clotting factor for blood coagulation.Traditional treatments have relied heavily on regular injections of clotting factor, creating a lifelong dependency that many patients, like Terence Blue, have endured with mixed success.